These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11014644)
1. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance. Zhang QW; Tomita Y; Matsuzaki G; Yoshikawa M; Shimizu I; Nakashima Y; Sueishi K; Nomoto K; Yasui H Transplantation; 2000 Sep; 70(6):906-16. PubMed ID: 11014644 [TBL] [Abstract][Full Text] [Related]
2. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178 [TBL] [Abstract][Full Text] [Related]
3. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells. Zhang QW; Mayumi H; Umesue M; Tomita Y; Nomoto K; Yasui H Transplantation; 1997 Jun; 63(11):1667-73. PubMed ID: 9197364 [TBL] [Abstract][Full Text] [Related]
4. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702 [TBL] [Abstract][Full Text] [Related]
5. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578 [TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice. Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598 [TBL] [Abstract][Full Text] [Related]
7. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice. Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974 [TBL] [Abstract][Full Text] [Related]
8. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance? Tomita Y; Mayumi H; Eto M; Nomoto K J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891 [TBL] [Abstract][Full Text] [Related]
9. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance. Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417 [TBL] [Abstract][Full Text] [Related]
10. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice. Mayumi H; Good RA Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882 [TBL] [Abstract][Full Text] [Related]
11. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907 [TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice. Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens. Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319 [TBL] [Abstract][Full Text] [Related]
14. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice. Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338 [TBL] [Abstract][Full Text] [Related]
15. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514 [TBL] [Abstract][Full Text] [Related]
16. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A. Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906 [TBL] [Abstract][Full Text] [Related]
17. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Okano S; Shimizu I; Yasunami Y; Kajiwara T; Yoshikai Y; Taniguchi M; Nomoto K; Yasui H J Immunol; 2006 Dec; 177(12):8400-9. PubMed ID: 17142737 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system. Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. Mayumi H; Good RA J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cyclophosphamide-induced tolerance to IE-encoded alloantigens--evidence of clonal deletion in MHC antigen-reactive cells for skin allograft rejection. Tomita Y; Ayukawa K; Yoshikai Y; Nomoto K Transplantation; 1992 Mar; 53(3):602-12. PubMed ID: 1347961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]